Skip to content

Psychedelic-assisted therapy: all studies

Page 223 of 294: studies 2,221 to 2,230 of 2,936, newest first. Back to the psychedelic-assisted therapy overview

Research

O uso de psilocibina é eficaz no tratamento de depressão?

Brazilian Journal of Health Review July 3, 2023 Edson Santana Gois Filho, Ana Letícia Fiscina Reis, Marco Antonio Galvão Martins de Farias et al. 1 citation

Os Inibidores da Recaptação de Serotonina (ISRS) foram descobertos na década de 1980 e, desde então, são a primeira linha para o tratamento da depressão. Nos últimos anos, pesquisas para busca de novas terapias farmacológicas vem tomando visibilidade com a descoberta dos efeitos antidepressivos dos psicodélicos. Dentro deles, destaca-se a Psilocibina, um alcalóide advindo do fungo Psilocybe...

A Review of MDMA-Assisted Therapy for Posttraumatic Stress Disorder.

Focus July 1, 2023 Benjamin R. Lewis, Kevin Byrne 9 citations

Posttraumatic stress disorder (PTSD) is a common chronic and disabling psychiatric disorder that may develop after exposure to a traumatic life event. There are existing evidence-based psychotherapies and pharmacotherapies for PTSD; however, these treatments have significant limitations. 3,4-methylenedioxymethamphetamine (MDMA) was granted "breakthrough therapy" status by the U.S. Food and Drug...

From recent advances in underlying neurocircuitry of fear and anxiety to promising pharmacotherapies for PTSD: The saga of heart, sex and the developing brain.

Neuropharmacology July 1, 2023 Joanna Dabrowska 6 citations

Available pharmacotherapies for anxiety disorders and post-traumatic stress-disorder (PTSD) have limited efficacy, but no new anxiolytic drug has been approved for treatment since the 1980s. In this issue of Neuropharmacology on "Fear, anxiety and PTSD: from cellular mechanisms to translational approaches", we review the currently recommended pharmacotherapy for PTSD and discuss promising...

Importance of Integrating Spiritual, Existential, Religious, and Theological Components in Psychedelic-Assisted Therapies.

JAMA Psychiatry July 1, 2023 Roman Palitsky, Deanna M Kaplan, Caroline Peacock et al. 86 citations

Mounting evidence supports the role of spiritual, existential, religious, and theological components in mediating psychedelic-assisted therapy, yet integration of these elements into the clinical setting is lagging. Although psychedelic-assisted therapy commonly produces spiritually, existentially, religiously, or theologically relevant experiences for patients, these have not been...

Effect of LSD and music on the time-varying brain dynamics.

Psychopharmacology July 1, 2023 Iga Adamska, Karolina Finc 8 citations

Psychedelics are getting closer to being widely used in clinical treatment. Music is known as a key element of psychedelic-assisted therapy due to its psychological effects, specifically on the emotion, meaning-making, and sensory processing. However, there is still a lack of understanding in how psychedelics influence brain activity in experimental settings involving music listening. The main...

Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial

BJPsych Open July 1, 2023 Muhammad Ishrat Husain, Nicole Ledwos, Elise Fellows et al. 41 citations

Background Randomised controlled trials (RCTs) of psilocybin have reported large antidepressant effects in adults with major depressive disorder and treatment-resistant depression (TRD). Given psilocybin's psychedelic effects, all published studies have included psychological support. These effects depend on serotonin 2A (5-HT2A) receptor activation, which can be blocked by 5-HT2A receptor...

Suicide prevention and ketamine: insights from computational modeling

Frontiers in Psychiatry June 30, 2023 Colleen E. Charlton, Povilas Karvelis, Roger S McIntyre et al. 7 citations

Suicide is a pressing public health issue, with over 700,000 individuals dying each year. Ketamine has emerged as a promising treatment for suicidal thoughts and behaviors (STBs), yet the complex mechanisms underlying ketamine’s anti-suicidal effect are not fully understood. Computational psychiatry provides a promising framework for exploring the dynamic interactions underlying suicidality and...

DOI: 10.3389/fpsyt.2023.1214018 (opens in new tab) Full text (opens in new tab) Computational modeling Generative models Innovative approach Powerful tool +11

Alterations to self consciousness during mindfulness meditation and Flotation REST a comparative study

June 30, 2023 Matt P D Gwyther, Jane E. Aspell 3 citations preprint

Flotation-Reduced Environmental Stimulation Therapy (REST) and mindfulness meditation (MM) are known to induce altered states of consciousness (ASC) and self-consciousness. In this study, we use a phenomenological and predictive processing (PP) framework to compare the interventions alongside the psychedelic experience. Ego-dissolution scores were greater than ego-inflation scores in both...

Classical psychedelics in psychiatry - renaissance of interest and therapeutic perspectives.

Psychiatria Polska June 30, 2023 Askaniusz Jachimowski, Krzysztof Kucia

Substances that change the states of consciousness have been used in the therapeutics of traditional cultures for hundreds of years. In the Western cultural circle, scientific curiosity and hope for a breakthrough in the treatment of various mental disorders constituted the basis of the first wave of research on humans with the use of psychedelics. After synthesizing LSD, psychedelic substances...

DOI: 10.12740/PP/150053 (opens in new tab) Full text (opens in new tab) Pharmacotheraphy Psychedelics hallucinogens Entheogens Psychoactive drugs +4

Early Use in Psychotherapy

The History of MDMA June 29, 2023 Torsten Passie 2 citations

Abstract From 1977, MDMA was used in psychotherapy by a handful of psychiatrists and psychotherapists. They found it to be an ideal aid to psychotherapy as it does not affect ego-functions to the same extent as other psychedelic drugs. Its main effect seemed to be suppression of the fear response, allowing patients the opportunity to observe and reprocess painful memories. Another application...